BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31963601)

  • 1. Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use.
    Oddone E; Bollon J; Nava CR; Bugani M; Consonni D; Marinaccio A; Magnani C; Barone-Adesi F
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31963601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upcoming epidemic of asbestos-related malignant pleural mesothelioma in Taiwan: A prediction of incidence in the next 30 years.
    Lin RT; Chang YY; Wang JD; Lee LJ
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 3):463-470. PubMed ID: 30072200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forecast of Malignant Peritoneal Mesothelioma Mortality in Italy up to 2040.
    Oddone E; Bollon J; Nava CR; Minelli G; Imbriani M; Consonni D; Marinaccio A; Magnani C; Barone-Adesi F
    Int J Environ Res Public Health; 2020 Dec; 18(1):. PubMed ID: 33379304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Past trends and future prediction of mesothelioma incidence in an industrialized area of Italy, the Veneto Region.
    Girardi P; Bressan V; Merler E
    Cancer Epidemiol; 2014 Oct; 38(5):496-503. PubMed ID: 25200195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality rates from asbestos-related diseases in Italy during the first year of the COVID-19 pandemic.
    Fazzo L; Grande E; Zona A; Minelli G; Crialesi R; Iavarone I; Grippo F
    Front Public Health; 2023; 11():1243261. PubMed ID: 38292377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Italian pool of asbestos workers cohorts: mortality trends of asbestos-related neoplasms after long time since first exposure.
    Ferrante D; Chellini E; Merler E; Pavone V; Silvestri S; Miligi L; Gorini G; Bressan V; Girardi P; Ancona L; Romeo E; Luberto F; Sala O; Scarnato C; Menegozzo S; Oddone E; Tunesi S; Perticaroli P; Pettinari A; Cuccaro F; Mattioli S; Baldassarre A; Barone-Adesi F; Cena T; Legittimo P; Marinaccio A; Mirabelli D; Musti M; Pirastu R; Ranucci A; Magnani C;
    Occup Environ Med; 2017 Dec; 74(12):887-898. PubMed ID: 28775133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
    Mezei G; Chang ET; Mowat FS; Moolgavkar SH
    Scand J Work Environ Health; 2021 Jan; 47(1):85-86. PubMed ID: 32626907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Asbestos Consumption on Malignant Pleural Mesothelioma in Italy: Forecasts of Mortality up to 2040.
    Oddone E; Bollon J; Nava CR; Consonni D; Marinaccio A; Magnani C; Gasparrini A; Barone-Adesi F
    Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Authors' response: Mezei et al's "Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis".
    Marinaccio A; Consonni D; Mensi C; Mirabelli D; Migliore E; Magnani C; Di Marzio D; Gennaro V; Mazzoleni G; Girardi P; Negro C; Romanelli A; Chellini E; Grappasonni I; Madeo G; Romeo E; Ascoli V; Carrozza F; Angelillo IF; Cavone D; Tumino R; Melis M; Curti S; Brandi G; Mattioli S; Iavicoli S;
    Scand J Work Environ Health; 2021 Jan; 47(1):87-89. PubMed ID: 33388783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models.
    Marinaccio A; Montanaro F; Mastrantonio M; Uccelli R; Altavista P; Nesti M; Costantini AS; Gorini G
    Int J Cancer; 2005 May; 115(1):142-7. PubMed ID: 15645436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pleural mesothelioma mortality in Italy: time series reconstruction (1970-2009) and comparison with incidence (2003-2008)].
    Ferrante P; Mastrantonio M; Uccelli R; Corfiati M; Marinaccio A
    Epidemiol Prev; 2016; 40(3-4):205-14. PubMed ID: 27436254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of mesothelioma and lung cancer in a cohort of asbestos exposed workers.
    Gasparrini A; Pizzo AM; Gorini G; Seniori Costantini A; Silvestri S; Ciapini C; Innocenti A; Berry G
    Eur J Epidemiol; 2008; 23(8):541-6. PubMed ID: 18438715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009.
    Soeberg MJ; Leigh J; Driscoll T; Armstrong B; Young JM; van Zandwijk N
    Occup Environ Med; 2016 Mar; 73(3):187-94. PubMed ID: 26800709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
    Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W
    Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of mesothelioma in Lombardy, Italy: exposure to asbestos, time patterns and future projections.
    Mensi C; De Matteis S; Dallari B; Riboldi L; Bertazzi PA; Consonni D
    Occup Environ Med; 2016 Sep; 73(9):607-13. PubMed ID: 27312399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden.
    Hemminki K; Försti A; Chen T; Hemminki A
    BMC Cancer; 2021 Nov; 21(1):1189. PubMed ID: 34749677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
    Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
    Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
    Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
    J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant Pleural Mesothelioma: Accuracy of CT Against Immunohistochemical Test Among the Mexican Population.
    Gopar-Nieto R; Aguilar-Madrid G; Sotelo-Martínez L; Juárez-Pérez CA; Kelly-García J; Argote-Greene L; Ochoa-Vázquez MD; García-Bazán EM; Ramírez-Pérez J; Haro-García L; Jiménez-Ramírez C; Cabello-López A
    Arch Med Res; 2015 Feb; 46(2):107-11. PubMed ID: 25707292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant mesothelioma due to non-occupational asbestos exposure from the Italian national surveillance system (ReNaM): epidemiology and public health issues.
    Marinaccio A; Binazzi A; Bonafede M; Corfiati M; Di Marzio D; Scarselli A; Verardo M; Mirabelli D; Gennaro V; Mensi C; Schallemberg G; Merler E; Negro C; Romanelli A; Chellini E; Silvestri S; Cocchioni M; Pascucci C; Stracci F; Ascoli V; Trafficante L; Angelillo I; Musti M; Cavone D; Cauzillo G; Tallarigo F; Tumino R; Melis M;
    Occup Environ Med; 2015 Sep; 72(9):648-55. PubMed ID: 26045315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.